Andreas A Rostved1, Monica Sassi, Jørgen A L Kurtzhals, Søren Schwartz Sørensen, Allan Rasmussen, Christian Ross, Emile Gogineni, Charles Huber, Geetha Kutty, Joseph A Kovacs, Jannik Helweg-Larsen. 1. 1 Department of Infectious Diseases, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark. 2 Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD. 3 Centre for Medical Parasitology, Department of Clinical Microbiology, Rigshospitalet-Copenhagen University Hospital, and Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. 4 Department of Nephrology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark. 5 Department of Surgical Gastroenterology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark. 6 Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD. 7 Address correspondence to Jannik Helweg-Larsen, M.D., D.M.Sci., Department of Infectious Diseases, Rigshospitalet-Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Abstract
BACKGROUND: An outbreak of 29 cases of Pneumocystis jirovecii pneumonia (PCP) occurred among renal and liver transplant recipients (RTR and LTR) in the largest Danish transplantation centre between 2007 and 2010, when routine PCP prophylaxis was not used. METHODS: P. jirovecii isolates from 22 transplant cases, 2 colonized RTRs, and 19 Pneumocystis control samples were genotyped by restriction fragment length polymorphism and multilocus sequence typing analysis. Contact tracing was used to investigate transmission. Potential risk factors were compared between PCP cases and matched non-PCP transplant patients. RESULTS: Three unique Pneumocystis genotypes were shared among 19 of the RTRs, LTRs, and a colonized RTR in three distinct clusters, two of which overlapped temporally. In contrast, Pneumocystis control samples harbored a wide range of genotypes. Evidence of possible nosocomial transmission was observed. Among several potential risk factors, only cytomegalovirus viremia was consistently associated with PCP (P=0.03; P=0.009). Mycophenolate mofetil was associated with PCP risk only in the RTR population (P=0.04). CONCLUSION: We identified three large groups infected with unique strains of Pneumocystis and provide evidence of an outbreak profile and nosocomial transmission. LTRs may be infected in PCP outbreaks simultaneously with RTRs and by the same strains, most likely by interhuman transmission. Patients are at risk several years after transplantation, but the risk is highest during the first 6 months after transplantation. Because patients at risk cannot be identified clinically and outbreaks cannot be predicted, 6 months of PCP chemoprophylaxis should be considered for all RTRs and LTRs.
BACKGROUND: An outbreak of 29 cases of Pneumocystis jirovecii pneumonia (PCP) occurred among renal and liver transplant recipients (RTR and LTR) in the largest Danish transplantation centre between 2007 and 2010, when routine PCP prophylaxis was not used. METHODS:P. jirovecii isolates from 22 transplant cases, 2 colonized RTRs, and 19 Pneumocystis control samples were genotyped by restriction fragment length polymorphism and multilocus sequence typing analysis. Contact tracing was used to investigate transmission. Potential risk factors were compared between PCP cases and matched non-PCP transplant patients. RESULTS: Three unique Pneumocystis genotypes were shared among 19 of the RTRs, LTRs, and a colonized RTR in three distinct clusters, two of which overlapped temporally. In contrast, Pneumocystis control samples harbored a wide range of genotypes. Evidence of possible nosocomial transmission was observed. Among several potential risk factors, only cytomegalovirus viremia was consistently associated with PCP (P=0.03; P=0.009). Mycophenolate mofetil was associated with PCP risk only in the RTR population (P=0.04). CONCLUSION: We identified three large groups infected with unique strains of Pneumocystis and provide evidence of an outbreak profile and nosocomial transmission. LTRs may be infected in PCP outbreaks simultaneously with RTRs and by the same strains, most likely by interhuman transmission. Patients are at risk several years after transplantation, but the risk is highest during the first 6 months after transplantation. Because patients at risk cannot be identified clinically and outbreaks cannot be predicted, 6 months of PCP chemoprophylaxis should be considered for all RTRs and LTRs.
Authors: Ron Shapiro; James B Young; Edgar L Milford; James F Trotter; Rami T Bustami; Alan B Leichtman Journal: Am J Transplant Date: 2005-04 Impact factor: 8.086
Authors: K Solez; R B Colvin; L C Racusen; M Haas; B Sis; M Mengel; P F Halloran; W Baldwin; G Banfi; A B Collins; F Cosio; D S R David; C Drachenberg; G Einecke; A B Fogo; I W Gibson; D Glotz; S S Iskandar; E Kraus; E Lerut; R B Mannon; M Mihatsch; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; I Roberts; D Seron; R N Smith; M Valente Journal: Am J Transplant Date: 2008-02-19 Impact factor: 8.086
Authors: Mark G J de Boer; Lesla E S Bruijnesteijn van Coppenraet; Andre Gaasbeek; Stefan P Berger; Luc B S Gelinck; Hans C van Houwelingen; Peterhans van den Broek; Ed J Kuijper; Frank P Kroon; Jan P Vandenbroucke Journal: Clin Infect Dis Date: 2007-03-26 Impact factor: 9.079
Authors: Sabine Schmoldt; Regina Schuhegger; Thorsten Wendler; Ingrid Huber; Heidelore Söllner; Michael Hogardt; Helmut Arbogast; Jürgen Heesemann; Lutz Bader; Andreas Sing Journal: J Clin Microbiol Date: 2008-01-23 Impact factor: 5.948
Authors: Robert T Neff; Rahul M Jindal; David Y Yoo; Frank P Hurst; Lawrence Y Agodoa; Kevin C Abbott Journal: Transplantation Date: 2009-07-15 Impact factor: 4.939
Authors: N Arichi; H Kishikawa; Y Mitsui; T Kato; K Nishimura; R Tachikawa; K Tomii; H Shiina; M Igawa; Y Ichikawa Journal: Transplant Proc Date: 2009 Jan-Feb Impact factor: 1.066
Authors: Marwan M Azar; Elizabeth Cohen; Liang Ma; Ousmane H Cissé; Geliang Gan; Yanhong Deng; Kristen Belfield; William Asch; Matthew Grant; Shana Gleeson; Alan Koff; David C Gaston; Jeffrey Topal; Shelly Curran; Sanjay Kulkarni; Joseph A Kovacs; Maricar Malinis Journal: Clin Infect Dis Date: 2022-03-01 Impact factor: 9.079